Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Predictive value of combined analysis of pro-NPY and ERG in localized prostate cancer

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Epigenetic therapy in hematological cancers

    Research output: Contribution to journalReviewResearchpeer-review

  2. Subtyping of intraductal papillary mucinous neoplasms - pitfalls of MUC1 immunohistochemistry

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mycobacterium brisbanense lung infection facilitated by steroid induced adrenal insufficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The inflamed sputum in lower respiratory tract infection: l-lactate levels are correlated to neutrophil accumulation

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Comparison of methods for measuring antibiotic consumption in an intensive care unit

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Palliative Prostate Artery Embolization for Prostate Cancer: A Case Series

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

This study aimed to investigate if combined analysis of pro-Neuropeptide Y (NPY) and ERG expression in tumor tissue are associated with biochemical failure (BF), castration-based treatment, castration-resistant prostate cancer (CRPC), and prostate cancer (PCa)-specific death for men undergoing radical prostatectomy (RP) for PCa. This study included 315 patients, who underwent RP from 2002 to 2005. Both pro-NPY and ERG expression were analyzed using immunohistochemistry and were scored as low or high and negative or positive, respectively. Risk of BF, castration-based treatment, CRPC, and PCa-specific death were analyzed with multiple cause-specific Cox regression analyses and stratified cumulative incidences using competing risk assessment. Median follow-up was 13.0 years (95% CI: 12.7-13.2). In total, 85.7% were pro-NPY high and 14.3% were pro-NPY low. The combined analyses of pro-NPY and ERG expression was not associated with risk of BF (p = 0.7), castration-based treatment (p = 0.8), CRPC (p = 0.4) or PCa-specific death (p = 0.5). In the multiple cause-specific Cox regression analysis, pro-NPY high and ERG positivity was not associated with BF (HR: 1.02; 95% CI 0.6-1.7; p = 0.94). In conclusion the combination of pro-NPY and ERG expression did not show association with risk of BF, castration-based treatment, CRPC, and PCa-specific death following RP.

Original languageEnglish
JournalAPMIS - Journal of Pathology, Microbiology and Immunology
Volume126
Issue number10
Pages (from-to)804-813
Number of pages10
ISSN0903-4641
DOIs
Publication statusPublished - Oct 2018

ID: 55350213